Regions Financial Corp Grifols Sa Transaction History

Regions Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$17.59 - $21.1 $99,576 - $119,447	-5,661 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$18.01 - $20.11 $15,542 - $17,354	-863 Reduced 13.23%	5,661 $114,000
Q4 2018 Jan 28, 2019	SELL	$17.44 - $21.53 $8,458 - $10,442	-485 Reduced 6.92%	6,524 $120,000
Q3 2018 Oct 22, 2018	SELL	$19.97 - $21.96 $2,316 - $2,547	-116 Reduced 1.63%	7,009 $149,000
Q2 2018 Jul 26, 2018	BUY	$20.16 - $24.68 $13,023 - $15,943	646 Added 9.97%	7,125 $153,000
Q1 2018 Apr 18, 2018	SELL	$20.31 - $24.95 $2,132 - $2,619	-105 Reduced 1.59%	6,479 $137,000
Q4 2017 Jan 18, 2018	BUY	$20.99 - $23.89 $138,198 - $157,291	6,584	6,584 $151,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.